Patch Server
The PatchServer brings automation to the classical patch clamp method.
Its unique pipette-based approach excels in high quality gigaseals, visual cell selection and fast compound application.
The PatchServer originated in 2008 as a research project of our electrophysiology group at NMI TT Pharmaservices to develop an automated patch clamp system for ultra fast compound applications and stem cell research.
Key features
-
Optical selection of the cells to be patch clamped
-
Fast compound application in the ms-range
Currently, the PatchServer is actively developed and used for drug screening and safety pharmacology.
A commercial version of the PatchServer is also beeing independently developed by Multichannel Systems GmbH (MCS). For more information, see the MCS PatchServer product page.